The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

GRIN2: Genomic Random Interval (GRIN)

Improved version of 'GRIN' software that streamlines its use in practice to analyze genomic lesion data, accelerate its computing, and expand its analysis capabilities to answer additional scientific questions including a rigorous evaluation of the association of genomic lesions with RNA expression. Pounds, Stan, et al. (2013) <doi:10.1093/bioinformatics/btt372>.

Version: 1.0
Depends: R (≥ 4.2.0)
Imports: biomaRt, circlize, ComplexHeatmap, data.table, dplyr, EnsDb.Hsapiens.v75, ensembldb, forcats, GenomeInfoDb, ggplot2, graphics, grDevices, grid, gridGraphics, Gviz, magrittr, stats, stringr, survival, tibble, tidyselect, utils, writexl
Suggests: knitr, rmarkdown
Published: 2024-11-19
DOI: 10.32614/CRAN.package.GRIN2
Author: Abdelrahman Elsayed ORCID iD [aut, cre, cph], Xueyuan Cao [aut], Lakshmi Anuhya patibandla [aut], Stanley Pounds [aut, cph]
Maintainer: Abdelrahman Elsayed <aelsayed at stjude.org>
BugReports: https://github.com/abdel-elsayed87/GRIN2/issues
License: GPL (≥ 3)
URL: https://github.com/abdel-elsayed87/GRIN2
NeedsCompilation: no
CRAN checks: GRIN2 results

Documentation:

Reference manual: GRIN2.pdf
Vignettes: Introduction to the GRIN2 Package (source, R code)

Downloads:

Package source: GRIN2_1.0.tar.gz
Windows binaries: r-devel: GRIN2_1.0.zip, r-release: not available, r-oldrel: not available
macOS binaries: r-release (arm64): not available, r-oldrel (arm64): not available, r-release (x86_64): not available, r-oldrel (x86_64): not available

Linking:

Please use the canonical form https://CRAN.R-project.org/package=GRIN2 to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.